nursingstudyhelp.com logo

Our Services

Get 15% Discount on your First Order

For this assignment, you will write a paper on the pharmacological management of the disease. The paper should include a review of the: · Disease

For this assignment, you will write a paper on the pharmacological management of the disease. The paper should include a review of the:

· Disease process:

Sickle cell anemia

· Pathophysiology of the disease state.

· Review of the pharmacological agents used for treatment and important information related to advanced practice nurse.

· Each student will clearly write a title for this topic: For examples, “Pharmacological Effects of Anti-Hypertensive Medications in the Management of Hypertension”.

 

Submission Instructions:

· The paper is to be clear and concise and students will lose points for improper grammar, punctuation, and misspelling.

· The paper should be formatted per the current APA and 5-7 pages in length, excluding the title, abstract and references page.

· Incorporate a minimum of 5 current (published within the last five years) scholarly journal articles within your work.

Share This Post

Email
WhatsApp
Facebook
Twitter
LinkedIn
Pinterest
Reddit

Order a Similar Paper and get 15% Discount on your First Order

Related Questions

Discussion    ERADICATION OF SMALLPOX, POLIO, AND COVID-19 Epidemiology WEEK 9: AT A

Discussion    ERADICATION OF SMALLPOX, POLIO, AND COVID-19 Epidemiology WEEK 9: AT A GLANCE  INFECTIOUS DISEASE FROM AN EPIDEMIOLOGIC PERSPECTIVE INTRODUCTION The scope of epidemiology has broadened over the years to include the global investigation of chronic, environmental, and genetic diseases and other health-related conditions. Yet, the practice of epidemiology

Antidepressant Medications Name Indication, starting dose, target symptoms, and affected neurotransmitters Half-life

Antidepressant Medications Name Indication, starting dose, target symptoms, and affected neurotransmitters Half-life (T1/2) CYP450 enzyme Notes/Notable side effects/Precautions SSRIs Citalopram (Celexa)  Escitalopram (Lexapro)  Fluoxetine (Prozac)  Fluvoxamine (Luvox)  Paroxetine (Paxil)  Sertraline (Zoloft)  SNRIs Venlafaxine (Effexor) Desvenlafaxine (Pristiq) Duloxetine (Cymbalta) Other Mirtazapine (Remeron) Trazadone (Desyrel) Vilazodone (Viibryd) Vortioxetine (Trintellix) Bupropion (Wellbutrin) This

EVIDENCE-BASED PRACTICE AND THE QUADRUPLE AIM Healthcare organizations continually seek to optimize healthcare performance. For years, this approach was a

EVIDENCE-BASED PRACTICE AND THE QUADRUPLE AIM Healthcare organizations continually seek to optimize healthcare performance. For years, this approach was a three-pronged one known as the Triple Aim, with efforts focused on improved population health, enhanced patient experience, and lower healthcare costs. More recently, this approach has evolved to a Quadruple